Showing 361-380 of 644 for: Cochrane Systematic Reviews > Respiratory 
- Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children
Cochrane Systematic Reviews, 29-Mar-2009
The addition of a long acting beta agonist (LABA) to inhaled corticosteroid (ICS) therapy can improve asthma symptoms and reduce exacerbations. The addition of LABA may also have an ICS-sparing effect and permit a reduction in ICS maintenance dose.
- Long‐acting beta2‐agonists for bronchiectasis
Cochrane Systematic Reviews, 23-Oct-2001
Symptoms of bronchiectasis include chronic productive cough, wheeze, breathlessness and recurrent infections of the lower respiratory tract. Long-acting bronchodilators are being used more frequently in the management of people with this condition.
- Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid
Cochrane Systematic Reviews, 22-Jul-2014
Asthma is a common respiratory disease among both adults and children and short acting inhaled beta-2 agonists are used widely for 'reliever' bronchodilator therapy. Long acting beta-2 agonists (LABA) were introduced as prospective 'symptom controllers' i
- Long-acting beta2-agonists for chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 11-Oct-2013
Chronic obstructive pulmonary disease (COPD) is a respiratory disease that causes progressive symptoms of breathlessness, cough and mucus build-up. It is the fourth or fifth most common cause of death worldwide and is associated with significant healthcar
- Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 21-Nov-2012
Chronic obstructive pulmonary disease (COPD) is characterised by partially reversible airflow limitation. Many patients have little reversibility to short acting bronchodilators, but long acting bronchodilators are frequently advocated.
- Long‐acting beta2‐agonists versus theophylline for maintenance treatment of asthma
Cochrane Systematic Reviews, 18-Jul-2007
Theophylline and long acting beta-2 agonists are bronchodilators used for the management of persistent asthma symptoms, especially nocturnal asthma. They represent different classes of drug with differing side-effect profiles.
- Low level laser therapy for treating tuberculosis
Cochrane Systematic Reviews, 19-Apr-2006
The main treatment for tuberculosis is antituberculous drugs. Low level laser therapy is used as an adjunct to antituberculous drugs, predominantly in the former Soviet Union and India.
- Lung lavage for meconium aspiration syndrome in newborn infants
Cochrane Systematic Reviews, 29-Mar-2013
Meconium aspiration syndrome (MAS) can occur when a newborn infant inhales a mixture of meconium and amniotic fluid into the lungs around the time of delivery. Other than supportive measures, little effective therapy is available. Lung lavage may be a pot
- Lung protective ventilation strategy for the acute respiratory distress syndrome
Cochrane Systematic Reviews, 28-Feb-2013
Patients with acute respiratory distress syndrome and acute lung injury require mechanical ventilatory support. Acute respiratory distress syndrome and acute lung injury are further complicated by ventilator-induced lung injury. Lung protective ventilatio
- Lung volume reduction surgery for diffuse emphysema
Cochrane Systematic Reviews, 14-Oct-2016
Lung volume reduction surgery (LVRS) performed to treat patients with severe diffuse emphysema was reintroduced in the nineties. Lung volume reduction surgery aims to resect damaged emphysematous lung tissue, thereby increasing elastic properties of the l
- Macrolide antibiotics for cystic fibrosis
Cochrane Systematic Reviews, 14-Nov-2012
Macrolide antibiotics may have a modifying role in diseases which involve airway infection and inflammation, like cystic fibrosis.
- Macrolides for diffuse panbronchiolitis
Cochrane Systematic Reviews, 25-Jan-2015
Diffuse panbronchiolitis (DPB) is a chronic airways disease predominantly affecting East Asians. Macrolides, a class of antibiotics, have been used as the main treatment for DPB, based on evidence from retrospective and non-randomised studies.
- Macrolides versus placebo for chronic asthma
Cochrane Systematic Reviews, 22-Nov-2021
Asthma is a chronic disease in which inflammation of the airways causes symptomatic wheezing, coughing and difficult breathing. Macrolides are antibiotics with antimicrobial and anti-inflammatory activities that have been explored for the long-term contro
- Magnesium sulfate for persistent pulmonary hypertension of the newborn
Cochrane Systematic Reviews, 18-Jul-2007
Persistent pulmonary hypertension of the newborn (PPHN) occurs in approximately 1.9 per 1000 newborns and may be more frequent in developing countries. There is strong evidence for the use of inhaled nitric oxide (iNO) and extracorporeal membrane oxygenat
- Magnesium sulfate for treating exacerbations of acute asthma in the emergency department
Cochrane Systematic Reviews, 18-May-2016
Treatment of acute asthma is based on rapid reversal of bronchospasm and arresting airway inflammation. There is some evidence that intravenous magnesium can provide additional bronchodilation when given in conjunction with standard bronchodilating agents
- Manual therapy for asthma
Cochrane Systematic Reviews, 15-Feb-2011
A variety of manual therapies with similar postulated biologic mechanisms of action are commonly used to treat patients with asthma. Manual therapy practitioners are also varied, including physiotherapists, respiratory therapists, chiropractic and osteopa
- Mast‐cell stabilising agents to prevent exercise‐induced bronchoconstriction
Cochrane Systematic Reviews, 20-Oct-2003
Exercise-induced bronchoconstriction (or asthma) following strenuous physical exertion is common and can cause sub-optimal performance, symptoms such as cough, dyspnea, wheeze, chest tightness, and can lead people to avoid physical activity. Management fo
- Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child
Cochrane Systematic Reviews, 12-Sep-2012
Some breastfed infants with atopic eczema benefit from elimination of cow milk, egg, or other antigens from their mother's diet. Maternal dietary antigens are also known to cross the placenta.
- Mechanical insufflation-exsufflation for people with neuromuscular disorders
Cochrane Systematic Reviews, 22-Dec-2013
People with neuromuscular disorders (NMDs) may have weak respiratory (breathing) muscles which makes it difficult for them to effectively cough and clear mucus from the lungs. This places them at risk of recurrent chest infections and chronic lung disease
- Mechanical ventilation for newborn infants with respiratory failure due to pulmonary disease
Cochrane Systematic Reviews, 21-Oct-2002
Mechanical ventilation (MV) for critically ill neonates was introduced in the 1960s and is now standard treatment for infants with severe RDS. However, the degree to which this made a contribution to the outcome of such infants is uncertain.
